QLGN - Qualigen Therapeutics Inc. (QLGN) CEO Michael Poirier on Q1 2021 Results - Earnings Call Transcript
Qualigen Therapeutics, Inc. (QLGN)
Q1 2021 Results Conference Call
August 18, 2020 4:30 PM ET
Company Participants
Yvonne Briggs - LHA Investor Relations
Michael Poirier - Chairman, President and CEO
Christopher Lotz - Chief Financial Officer
Conference Call Participants
James Molloy - Alliance Global Partners
David Bautz - Zacks Small-Cap Research
Presentation
Operator
Good day, and welcome to the Qualigen Therapeutics Business Update Conference Call. All participants will be in listen-only mode. [Operator Instruction]. After today's presentation, there will be an opportunity to ask questions. Please note, this event is being recorded.
I would now